Company profile: Bioqual
1.1 - Company Overview
Company description
- Provider of AAALAC-accredited pre-clinical research and model development services, offering in vivo studies in small and large animal models, in vitro services (sample processing, virus stock generation, and assays including virus neutralization, hemagglutination inhibition, and quantitative PCR), vaccine evaluation (therapeutics and microbicides), drug therapy testing, and consulting.
Products and services
- In Vitro Services: Delivers laboratory-grade sample processing, virus stock generation, and assay execution—including virus neutralization, hemagglutination inhibition, and quantitative PCR—for analytic support of infectious disease investigations
- In Vivo Pre-Clinical Research Services: Conducts studies using small and large animal models within AAALAC-accredited facilities, leveraging state-of-the-art resources and experienced scientists, veterinarians, and animal care personnel for commercial and government infectious disease investigations
- Vaccine Evaluation: Executes preclinical-grade vaccine evaluation programs, including development and testing of vaccine therapeutics and microbicides, supporting infectious disease investigations for commercial and government clients
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bioqual
Cambrex
HQ: United States
Website
- Description: Provider of end-to-end small molecule drug substance and drug product development and manufacturing, analytical services and testing, IND-enabling services, and process development. Supports research through commercial scale, covering various dosage forms, streamlining IND submissions, and ensuring regulatory compliance and product safety for small molecule therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambrex company profile →
Cytel
HQ: United States
Website
- Description: Provider of statistical software and advanced analytics for clinical trial design and execution, offering East and Solara for optimal trial design, Real World Evidence services, Synthetic Control Arms, and Data Monitoring Committees, helping biotech and pharmaceutical companies navigate uncertainty and make evidence-based decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytel company profile →
Arcus Medica
HQ: United States
Website
- Description: Provider of medical and scientific communications consulting services with full-service capabilities and expertise in oncology, hematology, transplant, and rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arcus Medica company profile →
ApiJect
HQ: United States
Website
- Description: Provider of a medical technology platform enabling scalable manufacturing and fill-finish of prefilled, single-dose injectors using Blow-Fill-Seal aseptic packaging. Offers the Prefilled ApiJect Injector with a pen needle–style hub; technology licensing for BFS mold/device design, development and production support; and design and engineering services for BFS fill-finish of temperature-sensitive biologics and vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ApiJect company profile →
Veranova
HQ: United States
Website
- Description: Provider of research, development, and manufacturing of sophisticated, complex active pharmaceutical ingredients (APIs) for pharmaceutical and biotech industries, applying scientific expertise and diversified talent to create fresh approaches to resolving business issues and enhancing stakeholder value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veranova company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bioqual
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bioqual
2.2 - Growth funds investing in similar companies to Bioqual
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bioqual
4.2 - Public trading comparable groups for Bioqual
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →